Erytech announces trading resumption of its ordinary shares on Euronext Paris Post author:admERY Post published:November 10, 2017 Post category:Newsroom ERYTECH Pharma announces trading resumption of its ordinary shares on Euronext Paris as from 4:00pm CET. You Might Also Like ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update May 14, 2018 ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021 ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update May 2, 2019
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021
